← Leaderboards
Heather L Gray-Edwards
Auburn University At Auburn
$4,340,720
Attributed
$6,694,472
Total exposure
6
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.3M · FY2013–25$2M$1.5M$1M$500K$0
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$6,694,472 · 6
By mechanism
R01$5,085,915 · 3
K08$906,459 · 1
R61$505,640 · 1
F32$196,458 · 1
Top collaborators
- Miguel S Esteves5 shared
- Douglas R Martin5 shared
- Thomas J. Meade5 shared
Most similar at Auburn University At Auburn
Same institution · by research overlap
- Douglas R Martin$3,447,411
Others in their field
Top investigators on “Mouse Model”
- Dennis R. Burton · Scripps Research Institute$280,661,242
- David Heimbrook · Leidos Biomedical Research, Inc.$84,491,283
- Kc Kent Lloyd · University Of California At Davis$74,285,556
- Alan F Horwitz · University Of Virginia Charlottesville$73,668,592
- Stanley B Prusiner · University Of California San Francisco$61,905,394
- Ed Lein · Allen Institute$59,425,748
Research focus
Mouse ModelGene TherapyBiological MarkersAnimal ModelMagnetic Resonance ImagingBrainTissuesAffectFelis CatusSandhoff DiseaseIntravenousEnzymesLysosomal Storage DiseasesThalamic StructureSafetyDisease ProgressionInjectionsBiodistributionDependovirusExperimental StudyAnimalsClinical TrialsGangliosidoses Gm2G(M2) Ganglioside
Grant awards (17)
AAV Gene Therapy for Sialidosis: from Mice to IND$654,844
R01 · FY2025 · NS · contact PI
Evaluating the efficiency of in vivo gene transfer to correct the molecular neuropathology causing psychiatric disease in MSUD$613,528
R01 · FY2025 · NS · contact PI
AAV Gene Therapy for Sialidosis: from Mice to IND$679,207
R01 · FY2024 · NS · contact PI
Real-Time Tracking of Gene Therapy by Bioactivated MR contrast Probes$548,624
R01 · FY2024 · NS
Real-Time Tracking of Gene Therapy by Bioactivated MR contrast Probes$659,071
R01 · FY2023 · NS
Generation of a Large Animal Model of Sialidosis to Enable Future Translation of Novel Therapeutics$505,640
R61 · FY2023 · NS · contact PI
Real-Time Tracking of Gene Therapy by Bioactivated MR contrast Probes$655,861
R01 · FY2022 · NS
Real-Time Tracking of Gene Therapy by Bioactivated MR contrast Probes$645,047
R01 · FY2021 · NS
Global AAV gene therapy of Tay-Sachs disease in sheep.$189,401
K08 · FY2021 · NS · contact PI
Real-Time Tracking of Gene Therapy by Bioactivated MR contrast Probes$629,733
R01 · FY2020 · NS
Global AAV gene therapy of Tay-Sachs disease in sheep.$189,401
K08 · FY2020 · NS · contact PI
Global AAV gene therapy of Tay-Sachs disease in sheep.$189,401
K08 · FY2019 · NS · contact PI
Global AAV gene therapy of Tay-Sachs disease in sheep.$169,128
K08 · FY2018 · NS · contact PI
Global AAV gene therapy of Tay-Sachs disease in sheep.$169,128
K08 · FY2017 · NS · contact PI
In vivo magnetic resonance-based analysis of inherited neurologic disease after g$68,726
F32 · FY2015 · NS · contact PI
In vivo magnetic resonance-based analysis of inherited neurologic disease after g$65,498
F32 · FY2014 · NS · contact PI
In vivo magnetic resonance-based analysis of inherited neurologic disease after g$62,234
F32 · FY2013 · NS · contact PI